General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Northwest Biotherapeutics: Q1 Earnings Snapshot | news.google.com • |
Northwest Bio: Another Small Filing Delay | seekingalpha.com • |
Northwest Bio: Is There Ever Going To Be A Right Time? | seekingalpha.com • |
Biotech Firm Claims Citadel, Other Market Makers Manipulated Stock Price | 247wallst.com • |
NWBO Stock Alert: Northwest Bio Slams Citadel Securities in New Lawsuit | investorplace.com • |
Northwest Biotherapeutics: Data Is Done, Just Wait For Approval | seekingalpha.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-10 | 2024-03 | 0 | -0.02 | N/A | N/A |
2024-03-05 | 2023-12 | 0 | -0.02 | N/A | N/A |
2023-11-09 | 2023-09 | 0 | -0.02 | N/A | N/A |
2023-08-09 | 2023-06 | 0 | -0.01 | N/A | N/A |
2023-05-10 | 2023-03 | 0 | -0.01 | N/A | N/A |
2023-02-28 | 2022-12 | 0 | -0.03 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2014-03-11 | Oppenheimer | Downgrade | Outperform | Perform |
2013-10-15 | Oppenheimer | Upgrade | Outperform | |
2013-09-18 | Summer Street Research | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2015-06-29 | COGNATE BIOSERVICES, INC. | Beneficial Owner (10% or more) | 18.46M | Sale |
2015-11-04 | WOODFORD INVESTMENT MANAGEMENT LLP | Beneficial Owner (10% or more) | 18.32M | Ownership Statement |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2016-09-29 | Woodford Investment Management LLP | 25.92M | 13.99M | 20.79% |
2016-09-29 | Credit Suisse/ | 1.90M | 1.03M | 1.52% |
2016-09-29 | Vanguard Group, Inc. (The) | 1.38M | 744.63K | 1.11% |
2016-09-29 | Goldman Sachs Group, Inc. | 994.70K | 537.14K | 0.80% |
2016-09-29 | BlackRock Institutional Trust Company, N.A. | 717.91K | 387.67K | 0.58% |
2016-09-29 | Millennium Management LLC | 357.41K | 193.00K | 0.29% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2016-06-29 | Vanguard Total Stock Market Index Fund | 968.77K | 561.89K | 0.78% |
2016-06-29 | Vanguard Extended Market Index Fund | 546.67K | 317.07K | 0.44% |
2016-08-30 | Fidelity Extended Market Index Fund | 158.54K | 53.90K | 0.13% |
2016-08-30 | Fidelity Total Market Index Fund | 60.54K | 20.58K | 0.05% |
2016-06-29 | Vanguard Institutional Index-Inst Total Stock Market Ind | 33.90K | 19.66K | 0.03% |
2016-08-30 | Fidelity NASDAQ Composite Index Fund | 27.00K | 9.18K | 0.02% |
Split | Date |
---|---|
0.0625 : 1 | 2012-09-26 |
0.06667 : 1 | 2007-06-28 |
Should drop TLD tomorrow after Bidens speech.
I made my stake but the difference is it’s based on what I have calculated and to be honest I know after 30+ years in biotech the game. I know that it looks good based on DNDN sipucel and the researchers. I do not know what Wall Street and the shorts/manipulation will do. I know a crossover study is the most complex trial to decrypt and that the FDA is in chaos. That is why no matter how good it seems it’s 50/50
With the CVM news long standing pumpers said it was a cure but mysteriously when the stock flew to $40 and then reversed they vanished and these were guys you thought were gurus. Never trust anyone just do your own due diligence and at least that way whatever happens you own it
In fact the bulls and pumpers on this board could actually be shorts driving the price higher to cash in with bad news.
It’s 50/50
I’m an not a short folks but I just want the people here to understand this is far more complex that the hype on this boards understands. I’m sure a certain percentage of the people that read this board are investing far more than they should and need to understand it’s a dice shot even with good data. The manipulation factor can even lead to disappointment. If you are going to post bullish posts please do it with a disclaimer so some guy doesn’t ruin his life at the crap table.
The FDA is in chaos and you have one hour to present your case with them. I think it has to be airtight and you have to educate and convince these guys it works. The corruption complicated it even more because these clowns are actually employed by big pharma
Crossover studies are the most complex to decrypt and with the length of this one it’s boxcars full of material to sift through.
I think the delay signals that they have issues with data. I think there’s clinical benefit but I don’t think that they can show beyond a doubt that it’s irrefutable and that is a real possibility.
Houston we have a problem!
And fuck AF he’s just the other side of the stupidity. He doesn’t have a clue just like the longs
It’s almost pitiful seeing these unrealistic long chatter away about shit they do not know and understand
Be advised you simply do not understand the layers involved. Clinical, political and corporate influence. You have these government employees making 200k a year promised jobs in the private sector paying 10x that when they leave if they only render unto Caesar. Big pharma owns these idiots
It’s a dice toss at best
Don’t get ahead of yourself. The complexity of the FDA is far far more than even the best analyst understand
They are looking at massive legal action if they haven’t disclosed material events but what’s to lose? It’s 50/50
Fact is that there has never been a company that waited to publish before disclosing TLD. Why? I think it is because it’s way to complex to sort out and they are having trouble. Anybody have that answer?
I was the largest shareholder in U S Bioscience in the 90’s and their drug Amofistine was shot down by the FDA and the drug was bought out of a BK only to eventually being approved.
I’ve seen it and in fact lived it
Big pharma understands it and won’t touch things with a 10 ft pole until they are all addressed and why should they when instead of getting carried away and paying 10 billion they can just wait until things fall apart and buy it in a BK eg. Dendreon